We are live on ! Find out more
GT

Greenleaf Trust Portfolio holdings

AUM $10.4B
1-Year Est. Return 0.97%
This Fund
S&P 500
This Quarter Est. Return
+2.81%
1 Year Est. Return
+0.97%
3 Year Est. Return
+37.24%
5 Year Est. Return
+56.69%
10 Year Est. Return
+246.06%
AUM
$3.81B
AUM Growth
+$8.97M
Cap. Flow
-$86.1M
Cap. Flow %
-2.26%
Top 10 Hldgs %
85.83%
Holding
256
New
47
Increased
84
Reduced
80
Closed
12

Top Sells

Rank Stock Value
1
SYK icon
Stryker
SYK
+$130M
2
LLTC
Linear Technology Corp
LLTC
+$4.38M
3
GILD icon
Gilead Sciences
GILD
+$3.72M
4
PII icon
Polaris
PII
+$3.44M
5
AFL icon
Aflac
AFL
+$2.4M

Sector Composition

Rank Sector Weight
1 Healthcare 82.02%
2 Financials 2.52%
3 Technology 2.29%
4 Consumer Staples 1.51%
5 Communication Services 1.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NKE icon
51
Nike
NKE
$64.1B
$5.55M 0.15%
109,164
-19,464
-15% -$998K
ILMN icon
52
Illumina
ILMN
$29.5B
$5.44M 0.14%
43,644
-11,462
-21% -$1.54M
PPLI
53
People Inc
PPLI
$3.12B
$5M 0.13%
431,361
-44,014
-9% -$515K
AMBA icon
54
Ambarella
AMBA
$3.04B
$4.92M 0.13%
90,953
-19,897
-18% -$1.2M
ACWX icon
55
iShares MSCI ACWI ex US ETF
ACWX
$11.2B
$4.91M 0.13%
122,018
-7,860
-6% -$318K
TROW icon
56
T. Rowe Price
TROW
$25.5B
$4.76M 0.12%
63,208
-671
-1% -$47.5K
IJT icon
57
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.13B
$4.56M 0.12%
60,750
-3,148
-5% -$222K
AMT icon
58
American Tower
AMT
$83.5B
$4.54M 0.12%
42,969
-28
-0.1% -$3.04K
IJS icon
59
iShares S&P Small-Cap 600 Value ETF
IJS
$8.12B
$4.36M 0.11%
62,236
-3,600
-5% -$236K
MJN
60
DELISTED
Mead Johnson Nutrition Company
MJN
$4.16M 0.11%
58,773
-16,009
-21% -$1.19M
MSFT icon
61
Microsoft
MSFT
$2.9T
$3.93M 0.1%
63,227
+2,802
+5% +$169K
VFC icon
62
VF Corp
VFC
$5.92B
$3.75M 0.1%
74,655
-27,777
-27% -$1.44M
DOX icon
63
Amdocs
DOX
$6.03B
$3.68M 0.1%
63,109
-565
-0.9% -$33.3K
COR icon
64
Cencora
COR
$62B
$3.62M 0.1%
46,284
-10,294
-18% -$803K
WSM icon
65
Williams-Sonoma
WSM
$27.5B
$3.35M 0.09%
138,390
-4,630
-3% -$118K
VTR icon
66
Ventas
VTR
$47.5B
$3.15M 0.08%
50,350
-2,867
-5% -$181K
JLL icon
67
Jones Lang LaSalle
JLL
$15.8B
$3.04M 0.08%
30,068
-8,545
-22% -$859K
BUD icon
68
AB InBev
BUD
$164B
$2.88M 0.08%
27,268
-8,593
-24% -$963K
RSP icon
69
Invesco S&P 500 Equal Weight ETF
RSP
$97.3B
$2.75M 0.07%
31,800
SDY icon
70
State Street SPDR S&P Dividend ETF
SDY
$22.1B
$2.56M 0.07%
29,866
+2,287
+8% +$192K
VWO icon
71
Vanguard FTSE Emerging Markets ETF
VWO
$117B
$2.53M 0.07%
70,794
+1,790
+3% +$65.6K
GE icon
72
GE Aerospace
GE
$364B
$2.53M 0.07%
16,718
+2,632
+19% +$382K
SPY icon
73
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$2.52M 0.07%
11,267
+1,180
+12% +$258K
BR icon
74
Broadridge
BR
$18.4B
$2.35M 0.06%
35,438
-261
-0.7% -$17K
ABBV icon
75
AbbVie
ABBV
$465B
$2.3M 0.06%
36,788
+1,078
+3% +$65.8K

Similar funds

Greenleaf Trust's Q4 2016 Portfolio in Review

As of Q4 2016, Greenleaf Trust held 256 positions worth $3.81B, up 0.24% from $3.8B the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Greenleaf Trust's Q4 2016 filing shows 47 new, 84 increased, 80 reduced and 12 closed positions. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 74,686 shares worth $8.35M. The largest sale was Stryker, an estimated $130M.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, down from 83% a quarter earlier, followed by Financials and Technology.

  • Greenleaf Trust's largest Q4 2016 buy was GW Pharmaceuticals Plc American Depositary Shares: 74,686 shares worth $8.35M.
  • Greenleaf Trust added most to iShares Core S&P 500 ETF in Q4 2016, an estimated $15.9M increase.
  • Greenleaf Trust's biggest Q4 2016 reduction was Stryker, cutting an estimated $130M.
  • Greenleaf Trust fully exited Linear Technology Corp in Q4 2016, selling an estimated $4.38M.
  • Greenleaf Trust's ten largest holdings make up 86% of its $3.81B portfolio in Q4 2016.
  • Greenleaf Trust opened 47 new positions and closed 12 in Q4 2016.
  • Greenleaf Trust's portfolio value rose 0.24% quarter-over-quarter to $3.81B.

Based on Greenleaf Trust's 13F filing for Q4 2016, filed 24 Jan 2017.